Next results are the Australian Adult trials, it will be another...

Next results are the Australian Adult trials, it will be another liquidity event before they need to raise capital. You just need to look at other stocks which have suffered the same fate, it becomes a daytraders play pen for a few weeks before the slow grind south.

This company might as well re-list and start again. At least 2 years ago the algorithms hadn't been trained by unblinded in-house Australian trials.

I will never own another ResApp share until they prove with US clinical data and proper statistical reporting that their algorithms work, Ill be happy to at whatever price.